...
首页> 外文期刊>Lipids in Health Disease >The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial
【24h】

The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial

机译:植物甾烷醇酯酸奶在土耳其人群中降低胆固醇的功效:一项双盲,安慰剂对照试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background We evaluated the cholesterol lowering efficacy of low-fat spoonable yoghurt with 1.9 g/d plant stanols as esters on plasma lipid profiles of Turkish subjects with mild to moderate hypercholesterolemia. Methods Using a randomised, double-blind, placebo-controlled study design, intervention (n?=?35) and control (n?=?35) groups consumed either 115 g low-fat yoghurt with 1.9 g/d plant stanols as esters or placebo yoghurt, respectively, for 4 weeks. Seventy subjects with untreated mild to moderate hypercholesterolemia (aged 23-65 years) were recruited. Changes in the lipid profile, including lipoproteins, apolipoproteins, and triglycerides, and anthropometric measurements were monitored at screening, baseline, and at the end of the second, third, and fourth weeks of intervention. The general linear model repeated measures procedure was used to test differences in the repeated continuous variables between study groups. Results Serum total cholesterol (4.6%), LDL cholesterol (6.3%), and non-HDL cholesterol (6.2%) concentrations were reduced significantly from baseline in the plant stanol group compared to the control group (p?=?0.007, p?=?0.005 and p?=?0.005, respectively). A variation in the response of serum total and LDL cholesterol between the subjects in plant stanol group was obtained. No clinically significant change in anthropometrical measurements was observed during the intervention. Conclusions The spoonable low-fat yoghurt with 1.9 g/d plant stanols as esters lowered total, LDL, and non-HDL cholesterol levels in Turkish subjects with mild to moderate hypercholesterolemia. Nevertheless variation in baseline cholesterol levels, genetic predisposition of the subjects and compliance may contribute to a large individual variability.
机译:背景我们评估了以1.9 g / d植物甾烷醇为酯的低脂可勺型酸奶的降胆固醇功效,该酯对中度至中度高胆固醇血症的土耳其受试者的血浆脂质谱具有影响。方法采用随机,双盲,安慰剂对照的研究设计,干预组(n = 35)和对照组(n = 35)分别食用115 g低脂酸奶和1.9 g / d植物甾烷醇作为酯类。或安慰剂酸奶分别服用4周。招募了70名未经治疗的轻度至中度高胆固醇血症(23-65岁)的受试者。在筛选,基线以及干预的第二,第三和第四周结束时,监测包括脂蛋白,载脂蛋白和甘油三酸酯在内的脂质分布的变化,以及人体测量。通用线性模型重复测量程序用于检验研究组之间重复连续变量的差异。结果与对照组相比,植物甾烷醇组的血清总胆固醇(4.6%),LDL胆固醇(6.3%)和非HDL胆固醇(6.2%)浓度均较基线水平显着降低(p <= 0.007,p <0.05)。分别为0.005和0.005。在植物甾烷醇组中,受试者之间的血清总胆固醇和LDL胆固醇的反应存在差异。干预期间未观察到人体测量学的临床显着变化。结论以1.9 g / d植物甾烷醇为酯的可勺式低脂酸奶可降低土耳其中度至中度高胆固醇血症受试者的总胆固醇,LDL和非HDL胆固醇水平。然而,基线胆固醇水平,受试者的遗传易感性和依从性的变化可能会导致较大的个体差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号